LON:MYX MYCELX Technologies (MYX) Share Price, News & Analysis → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free MYX Stock Alerts GBX 54.50 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share Today's Range 53.25▼ 54.5050-Day Range 45.50▼ 58.7752-Week Range N/AVolumeN/AAverage Volume21,442 shsMarket Capitalization£12.52 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 95 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsInsider Trades Get MYCELX Technologies alerts: Email Address Ad Chaikin AnalyticsWall Street legend who predicted 2021 tech crash issues new warningPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge About MYCELX Technologies Stock (LON:MYX)MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries. It also sells or leases its equipment; and sells consumable filtration media. The company was incorporated in 1994 and is headquartered in Norcross, Georgia.Read More MYX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYX Stock News HeadlinesNovember 16, 2023 | lse.co.ukEARNINGS AND TRADING: Tatton profit up; Mycelx to miss expectationsSeptember 22, 2023 | finance.yahoo.comMYCELX Technologies (LON:MYX) Is In A Good Position To Deliver On Growth PlansAugust 29, 2023 | msn.comCellmyx’s intelliFattechnology receives MDL approval from Health CanadaJuly 11, 2023 | marketwatch.comMyCelx Technologies Contract Extension, Prior Contract to Generate $2 Mln RevenueJuly 3, 2023 | marketwatch.comMyCelx Technologies Gets Contract From New Middle East CustomerMay 19, 2023 | finance.yahoo.comMYCELX Technologies Full Year 2022 Earnings: US$0.18 loss per share (vs US$0.073 loss in FY 2021)March 29, 2023 | finance.yahoo.comMYCELX TECHNOLOGIES CORPORATION (MYX.L) stock forecast and price targetMarch 18, 2023 | lse.co.ukMycelx Di Regulatory NewsDecember 8, 2022 | marketwatch.comMyCelx Technologies Shares Jump as It Expects to Post in Line FY ResultsOctober 7, 2022 | investing.comMyCelx Technologies Corp (MYXM)August 31, 2022 | lse.co.ukMycelx Di Share ChatAugust 22, 2022 | finance.yahoo.comMultiple insiders bought MYCELX Technologies Corporation (LON:MYX) stock earlier this year, a positive sign for shareholdersJuly 18, 2022 | finance.yahoo.comA number of insiders bought MYCELX Technologies Corporation (LON:MYX) stock last year, which is great news for shareholdersSee More Headlines Receive MYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MYCELX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorIndustrials Industry Pollution & Treatment Controls Sub-IndustryN/A Current SymbolLON:MYX CUSIPN/A CIKN/A Webwww.mycelx.com Phone+1-770-5343118FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetGBX 95 High Stock Price TargetGBX 95 Low Stock Price TargetGBX 95 Potential Upside/Downside+74.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,620,000.00 Net Margins-21.98% Pretax MarginN/A Return on Equity-24.64% Return on Assets-10.31% Debt Debt-to-Equity Ratio11.29 Current Ratio3.55 Quick Ratio2.97 Sales & Book Value Annual Sales£11.89 million Price / Sales1.05 Cash FlowGBX 27.83 per share Price / Cash Flow1.96 Book ValueGBX 41 per share Price / Book1.33Miscellaneous Outstanding Shares22,980,000Free FloatN/AMarket Cap£12.52 million OptionableNot Optionable Beta0.92 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Connie Mixon (Age 69)CEO & Executive Director Comp: $297.14kMr. Haluk Alper (Age 67)Co-Founder, President, Chief Science Officer & Executive Director Comp: $186.42kMr. John Mansfield Sr. (Age 92)Co-Founder & Chairman Emeritus Ms. Kimberly SlaytonCFO & SecretaryDr. Alexander MillarChief Strategy Officer & GM of Saudi ArabiaKey CompetitorsTekmar GroupLON:TGPDriver GroupLON:DRVFireAngel Safety Technology GroupLON:FAHydrogen Group Plc (HYDG.L)LON:HYDGSEC Newgate S.p.A. (SECG.L)LON:SECGView All CompetitorsInsidersConnie MixonBought 49,300 shares on 4/5/2024Total: £2.51 M ($51.00/share)Tom LambBought 2,000 shares on 3/25/2024Total: £100,000.00 ($50.00/share)Tom LambBought 6,000 shares on 3/20/2024Total: £294,000.00 ($49.00/share)View All Insider Transactions MYX Stock Analysis - Frequently Asked Questions Should I buy or sell MYCELX Technologies stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MYCELX Technologies in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MYX shares. View MYX analyst ratings or view top-rated stocks. What is MYCELX Technologies' stock price target for 2024? 2 brokerages have issued 1-year price objectives for MYCELX Technologies' stock. Their MYX share price targets range from GBX 95 to GBX 95. On average, they predict the company's share price to reach GBX 95 in the next year. This suggests a possible upside of 74.3% from the stock's current price. View analysts price targets for MYX or view top-rated stocks among Wall Street analysts. How have MYX shares performed in 2024? MYCELX Technologies' stock was trading at GBX 62 on January 1st, 2024. Since then, MYX stock has decreased by 12.1% and is now trading at GBX 54.50. View the best growth stocks for 2024 here. What other stocks do shareholders of MYCELX Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other MYCELX Technologies investors own include Telford Homes (TEF), Begbies Traynor Group (BEG), Advanced Computer Software Group (ASW), ASOS (ASC), Arcontech Group (ARC), Alliance Pharma (APH), Global X FTSE Andean 40 ETF (AND), Animalcare Group (ANCR), Advanced Medical Solutions Group (AMS) and ACMG.L (ACMG). How do I buy shares of MYCELX Technologies? Shares of MYX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:MYX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MYCELX Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
